A consensus protocol for the in silico optimisation of antibody fragments.

We present an in silico mutagenetic protocol for improving the binding affinity of single domain antibodies (or nanobodies, VHHs). The method iteratively attempts random mutations in the interacting region of the protein and evaluates the resulting binding affinity towards the target by scoring, with a collection of scoring functions, short explicit solvent molecular dynamics trajectories of the binder-target complexes. The acceptance/rejection of each attempted mutation is carried out by a consensus decision-making algorithm, which considers all individual assessments derived from each scoring function. The method was benchmarked by evolving a single complementary determining region (CDR) of an anti-HER2 VHH hit obtained by direct panning of a phage display library. The optimised VHH mutant showed significantly enhanced experimental affinity with respect to the original VHH it matured from. The protocol can be employed as it is for the optimization of peptides, antibody fragments, and (given enough computational power) larger antibodies.

[1]  Alessandra Corazza,et al.  Accurate Estimation of the Entropy of Rotation-Translation Probability Distributions. , 2016, Journal of chemical theory and computation.

[2]  Sarel J. Fleishman,et al.  AbDesign: An algorithm for combinatorial backbone design guided by natural conformations and sequences , 2015, Proteins.

[3]  Kwangmeyung Kim,et al.  Engineering nanoparticle strategies for effective cancer immunotherapy. , 2018, Biomaterials.

[4]  Ricardo Garcia,et al.  Adsorption orientations and immunological recognition of antibodies on graphene. , 2016, Nanoscale.

[5]  M. Nadeau,et al.  Proteins : Structure , Function , and Bioinformatics , 2022 .

[6]  Ruth Nussinov,et al.  FireDock: Fast interaction refinement in molecular docking , 2007, Proteins.

[7]  M. Vendruscolo,et al.  Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins , 2015, Proceedings of the National Academy of Sciences.

[8]  C. Dominguez,et al.  HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.

[9]  Miguel A. Soler,et al.  Binding affinity prediction of nanobody-protein complexes by scoring of molecular dynamics trajectories. , 2018, Physical chemistry chemical physics : PCCP.

[10]  Brian D. Weitzner,et al.  RosettaAntibodyDesign (RAbD): A general framework for computational antibody design , 2017, bioRxiv.

[11]  C. Maranas,et al.  OptMAVEn-2.0: De novo Design of Variable Antibody Regions against Targeted Antigen Epitopes , 2018, Antibodies.

[12]  Janice M. Reichert,et al.  Antibodies to watch in 2017 , 2016, mAbs.

[13]  R. D. Fisher,et al.  Structure of the complex between HER2 and an antibody paratope formed by side chains from tryptophan and serine. , 2010, Journal of molecular biology.

[14]  Z. Weng,et al.  Integrating atom‐based and residue‐based scoring functions for protein–protein docking , 2011, Protein science : a publication of the Protein Society.

[15]  Sherlyn Jemimah,et al.  Protein-protein interactions: scoring schemes and binding affinity. , 2017, Current opinion in structural biology.

[16]  M. DeLisa,et al.  Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein , 2018, Scientific Reports.

[17]  Alessandro Laio,et al.  Peptide biosensors for anticancer drugs: Design in silico to work in denaturizing environment. , 2018, Biosensors & bioelectronics.

[18]  A. de Marco,et al.  Nanobody-functionalized PEG-b-PCL polymersomes and their targeting study. , 2015, Journal of biotechnology.

[19]  J. Reichert Antibodies to watch in 2016 , 2016, mAbs.

[20]  Alessandra Corazza,et al.  Bluues: a program for the analysis of the electrostatic properties of proteins based on generalized Born radii , 2012, BMC Bioinformatics.

[21]  A. Marco Nanomaterial bio-activation and macromolecules functionalization: the search for reliable protocols , 2018 .

[22]  Miguel A Soler,et al.  Computational design of cyclic peptides for the customized oriented immobilization of globular proteins. , 2017, Physical chemistry chemical physics : PCCP.

[23]  Miguel A. Soler,et al.  Molecular dynamics simulations and docking enable to explore the biophysical factors controlling the yields of engineered nanobodies , 2016, Scientific Reports.

[24]  Michele Vendruscolo,et al.  Third generation antibody discovery methods: in silico rational design. , 2018, Chemical Society reviews.

[25]  Alessandro Laio,et al.  Native fold and docking pose discrimination by the same residue‐based scoring function , 2015, Proteins.

[26]  Alessandro Laio,et al.  In Silico Design of Short Peptides as Sensing Elements for Phenolic Compounds , 2016 .

[27]  L. Dardenne,et al.  Receptor–ligand molecular docking , 2013, Biophysical Reviews.

[28]  Serge Muyldermans,et al.  Nanobodies: natural single-domain antibodies. , 2013, Annual review of biochemistry.

[29]  Roberto A Chica,et al.  Protein Engineering, Design and Selection. , 2020, Protein engineering, design & selection : PEDS.

[30]  Andrew D Ellington,et al.  De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide , 2017, Scientific Reports.

[31]  P. Hudson,et al.  Engineered antibody fragments and the rise of single domains , 2005, Nature Biotechnology.

[32]  Improved Free-Energy Landscape Quantification Illustrated with a Computationally Designed Protein-Ligand Interaction. , 2018, Chemphyschem : a European journal of chemical physics and physical chemistry.

[33]  Miguel A. Soler,et al.  Distance-Based Configurational Entropy of Proteins from Molecular Dynamics Simulations , 2015, PloS one.

[34]  Ulrich Rothbauer,et al.  Under the Microscope: Single-Domain Antibodies for Live-Cell Imaging and Super-Resolution Microscopy , 2017, Front. Immunol..

[35]  D. Scaini,et al.  Quantification of Circulating Cancer Biomarkers via Sensitive Topographic Measurements on Single Binder Nanoarrays , 2017, ACS omega.

[36]  R. Borzilleri,et al.  Antibody-drug conjugates: current status and future directions. , 2014, Drug discovery today.

[37]  D. V. S. Ravikant,et al.  Improving ranking of models for protein complexes with side chain modeling and atomic potentials , 2013, Proteins.

[38]  Anna Russo,et al.  In Silico Generation of Peptides by Replica Exchange Monte Carlo: Docking-Based Optimization of Maltose-Binding-Protein Ligands , 2015, PloS one.

[39]  Mark Bates,et al.  Nanobodies: site-specific labeling for super-resolution imaging, rapid epitope-mapping and native protein complex isolation , 2015, eLife.